Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
Crinetics Pharmaceuticals Free Cash Flow : -425.18M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -425.18M |
| March 31, 2026 | -419.52M |
| December 31, 2025 | -383.68M |
| September 30, 2025 | -356.03M |
| June 30, 2025 | -307.80M |
| March 31, 2025 | -265.32M |
| December 31, 2024 | -229.81M |
| September 30, 2024 | -203.56M |
| June 30, 2024 | -185.05M |
| March 31, 2024 | -184.45M |
| December 31, 2023 | -171.00M |
| September 30, 2023 | -167.03M |
| June 30, 2023 | -161.35M |
| March 31, 2023 | -143.96M |
| December 31, 2022 | -116.86M |
| September 30, 2022 | -104.30M |
| June 30, 2022 | -90.95M |
| Date | Value |
|---|---|
| March 31, 2022 | -82.47M |
| December 31, 2021 | -89.02M |
| September 30, 2021 | -82.06M |
| June 30, 2021 | -74.35M |
| March 31, 2021 | -70.11M |
| December 31, 2020 | -62.21M |
| September 30, 2020 | -59.73M |
| June 30, 2020 | -55.24M |
| March 31, 2020 | -52.00M |
| December 31, 2019 | -46.87M |
| September 30, 2019 | -39.69M |
| June 30, 2019 | -32.03M |
| March 31, 2019 | -24.22M |
| December 31, 2018 | -20.52M |
| September 30, 2018 | -16.97M |
| June 30, 2018 | -13.49M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.796B |
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Bristol Myers Squibb Co. | 11.44B |
| Corcept Therapeutics, Inc. | 106.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -94.19M |
| Cash from Investing (Quarterly) | 26.29M |
| Cash from Financing (Quarterly) | 8.925M |
| Free Cash Flow Per Share (Quarterly) | -0.8973 |
| Free Cash Flow to Equity (Quarterly) | -94.05M |
| Free Cash Flow to Firm (Quarterly) | -94.71M |
| Free Cash Flow Yield | -5.02% |